Effects of an oncology Exercise therapy with equipment on the quality of life of oncological patients
- Conditions
- C00-C97Malignant neoplasms
- Registration Number
- DRKS00023912
- Lead Sponsor
- Klinik III (Hämatologie, Onkologie, Palliativmedizin) Zentrum für Innere Medizin Universitätsmedizin Rostock
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
men and women = 18 years of age,
- current or within the last 24 months a final-digit coded diagnosis according to ICD: C00* – C97* Malignant neoplasms
- are proficient in the German language in words and in writing,
- the patient must be physically and psychosocially able to participate in the care model (certificate of safety by the specialist)
Absolute contraindications: acute infectious diseases, fresh wounds, fresh myocardial infarction (< 4 weeks), unstable angina pectoris, clinically relevant heart failure (NYHA III and IV), higher-grade valve vitias, uncontrolled cardiac arrhythmia, chronic obstructive pulmonary disease, haemoglobulin < 4. 8 mmol/ l, platelets < 20 Gpt/ l, fresh thrombosis/ pulmonary embolism, new severe pain symptoms
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effects of oncological exercise therapy on patients' global quality of life (EORTC-QLQ-30)
- Secondary Outcome Measures
Name Time Method Patient reported outcomes (PROs)<br>- Fatigue (MFI-20)<br>- PNP (FACT/GOG-NTX-13 (version 4); PainDetect)<br>- Physical Activity Level (GSLTPAQ)<br>- Performance diagnostics<br>- Body composition (BIA)<br>- Balance (Timed up and go test, > 75 years)<br>- Force abilities (maximum force on equipment)<br>- cardiopulmonary performance (maximum and relative performance on<br>the bicycle ergometer)<br>• Other<br>- Dropout rate and reasons for premature termination of training<br>- Period 1-24 training session (stimulus density)<br>- Grounds for exclusion<br>- Adverse Events